Audiology and hearing aid practices sell for 5x to 9x EBITDA, measuring earnings before interest, taxes, depreciation, and amortization — the annual operating profit from device sales, fitting services, and recurring service plan revenue. Practices with strong unit volume growth, high premium technology adoption, multiple providers, robust recurring revenue, and diversified referral networks consistently achieve the upper range. The valuation spread reflects the volume trajectory, technology mix, and competitive positioning that buyers evaluate when pricing audiology acquisitions.

Unit sales volume and growth trajectory provide the foundational metric because hearing aid units sold multiplied by average selling price determines the majority of practice revenue. Practices selling 500-plus units annually demonstrate substantial market presence and sustained patient demand. Year-over-year growth of 5-10% in unit volume signals expanding referral relationships, effective marketing, and growing market penetration in a demographic tailwind driven by aging population and increased hearing loss awareness. Declining volumes raise competitive concerns about OTC alternatives and direct-to-consumer channels. Buyers model unit volume per provider to assess clinical productivity and growth capacity within the existing staffing structure.

Premium technology adoption rate determines average revenue per unit and gross margin per fitting, creating the most significant revenue quality variable. Premium hearing aids generating $2,500-4,000 per device produce substantially higher margins than entry-level products at $1,000-1,500. Practices achieving 60%+ premium adoption demonstrate effective patient counseling protocols that communicate technology benefits relative to lifestyle needs. Best-in-class practices use structured hearing needs assessments and demonstration protocols that help patients experience premium features before purchase decisions. Buyers value high premium adoption because it indicates pricing power, patient demographics, and counseling sophistication that sustain margins through market cycles.

Multiple audiologist providers ensure revenue continuity and expand capacity beyond single-provider constraints. Practices with three-plus audiologists distribute patient relationships across the clinical team, protecting revenue during any individual transition. Each audiologist fitting 150-200 units annually at $2,500+ average revenue generates $375K-500K in device revenue plus service income. Single-provider practices face succession risk that buyers discount 25-35% because patient loyalty often follows the individual audiologist rather than the practice brand. Multi-provider operations enable clinical specialization across pediatric audiology, tinnitus management, cochlear implant programming, and vestibular assessment, as analyzed in comparable provider-dependent models in our dental practice business valuation framework.

Recurring revenue from service plans, battery programs, accessories, and maintenance appointments creates predictable income beyond episodic device sales. Service plans at $300-600 annually per enrolled patient provide ongoing revenue covering cleaning, adjustments, and repair services. Practices with 60%+ enrollment rates demonstrate systematic aftercare programs generating additional patient touchpoints that drive hearing aid upgrade cycles every four to six years. Rechargeable hearing aid technology is shifting revenue from disposable batteries to annual service plan subscriptions, creating new recurring models. Buyers model recurring revenue separately because it smooths the inherently lumpy quarterly economics of device-dependent practices.

Referral network breadth across ENT physicians, primary care providers, and direct-to-consumer channels protects patient flow from dependency on any single source. Practices receiving referrals from 15-plus physician offices demonstrate broad professional relationships developed over years. ENT referrals deliver pre-diagnosed patients with documented hearing loss requiring amplification. Primary care referrals expand the addressable market through screening-identified candidates. Direct marketing including digital advertising, community hearing screenings, and retirement community outreach captures the growing self-referral segment. Balanced referral portfolios sustain volume because losing any single referring physician does not materially reduce patient appointments, similar to referral diversification tracked in physical therapy business valuation analysis.

OTC competitive strategy determines whether the practice maintains premium positioning or faces margin compression from consumer alternatives. Practices differentiating through comprehensive audiological evaluation, real ear measurement verification, custom fitting, and ongoing professional adjustment services maintain clear value separation from self-fit OTC devices designed for mild hearing loss. Professional-only services including tinnitus treatment, cochlear implant programming, vestibular assessment, and complex hearing loss management create revenue categories immune to OTC competition. Practices without articulated differentiation face patient price comparisons that compress device margins and threaten volume.

Adjusted EBITDA normalizes owner-audiologist compensation, device cost of goods, and discretionary expenses. A practice generating $2M annual revenue with $400K adjusted EBITDA at 7x values at $2.8M. A comparable practice with 600 annual units, 65% premium adoption, and four audiologists might command 8.5x, or $3.4M — the $600K premium reflects volume scale and provider depth. Smaller single-audiologist practices may use SDE multiples of 3x-5.5x, where seller's discretionary earnings captures total financial benefit to the owner-provider.

The buyer landscape includes PE-backed hearing care platforms paying 7x-9x EBITDA for multi-provider practices with growth trajectories, manufacturer retail divisions at 6x-8x building branded retail networks, ENT practice groups at 5.5x-7.5x adding audiology profit centers, and multi-location hearing chains at 5x-7x expanding geographic coverage. PE platforms pay premium multiples because they aggregate practices into networks achieving purchasing leverage on hearing aid inventory, centralized marketing efficiency, and shared administrative infrastructure. Companies with related healthcare service lines can reference our optometry business valuation for comparable device-dependent healthcare practice valuation benchmarks.